Skip to main content

Advertisement

Log in

Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Central nervous system primitive neuroectodermal tumors (CNS-PNET) and pineoblastomas (PBL) are rare in adulthood. Knowledge on clinical outcome and the efficacy and toxicities of chemotherapy in addition to radiotherapy is limited. Patients older than 21 years at diagnosis were followed in the observational arm of the prospective pediatric multicenter trial HIT 2000. After surgery, craniospinal irradiation and maintenance or sandwich chemotherapy were recommended. Radiotherapy was normo- (35.2 Gy; tumor region, 55.0 Gy; metastasis, 49.6 Gy) or hyperfractionated (40.0 Gy; tumor bed, 68.0 Gy; metastasis, 50–60 Gy). Maintenance chemotherapy consisted of eight courses (vincristine, lomustine, cisplatin). Sandwich chemotherapy included two cycles of postoperative chemotherapy followed by radiotherapy, and four courses of maintenance chemotherapy. Seventeen patients (CNS-PNET, n = 7; PBL, n = 10), median age 30 years, were included. Eight patients had a postoperative residual tumor and four patients metastatic disease. The median follow-up of ten surviving patients was 41 months. The estimated rates for 3-year progression-free survival (PFS) and overall survival were 68 ± 12 and 66 ± 13 %, respectively. PBL compared to CNS-PNET tended towards a better PFS, although the difference was not clear (p = 0.101). Both chemotherapeutic (maintenance, n = 6; sandwich, n = 8) protocols did not differ in their PFS and were feasible with acceptable toxicities. Intensified regimens of combined chemo- and radiotherapy are generally feasible in adults with CNS-PNET/PBL. The impact of intensified chemotherapy on survival should be further assessed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Picard D, Miller S, Hawkins CE, Bouffet E, Rogers HA, Chan TS, Kim SK, Ra YS, Fangusaro J, Korshunov A, Toledano H, Nakamura H, Hayden JT, Chan J, Lafay-Cousin L, Hu P, Fan X, Muraszko KM, Pomeroy SL, Lau CC, Ng HK, Jones C, Van Meter T, Clifford SC, Eberhart C, Gajjar A, Pfister SM, Grundy RG, Huang A (2012) Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol 13(8):838–848

    Article  PubMed Central  PubMed  Google Scholar 

  2. Gessi M, Setty P, Bisceglia M, zur Muehlen A, Lauriola L, Waha A, Giangaspero F, Pietsch T (2011) Supratentorial primitive neuroectodermal tumors of the central nervous system in adults: molecular and histopathologic analysis of 12 cases. Am J Surg Pathol 35(4):573–582

    Article  PubMed  Google Scholar 

  3. Hayden JT, Fruhwald MC, Hasselblatt M, Ellison DW, Bailey S, Clifford SC (2009) Frequent IDH1 mutations in supratentorial primitive neuroectodermal tumors (sPNET) of adults but not children. Cell Cycle 8(11):1806–1807

    Article  CAS  PubMed  Google Scholar 

  4. Biswas S, Burke A, Cherian S, Williams D, Nicholson J, Horan G, Jefferies S, Williams M, Earl HM, Burnet NG, Hatcher H (2009) Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation? Pediatr Blood Cancer 52(7):796–803

    Article  PubMed  Google Scholar 

  5. Boiardi A, Silvani A, Eoli M, Fariselli L, Zappacosta B, Salmaggi A (2000) Embryonal tumors in the adult population: implications in therapeutic planning. Neurol Sci 21(1):23–30

    Article  CAS  PubMed  Google Scholar 

  6. Chang SM, Lillis-Hearne PK, Larson DA, Wara WM, Bollen AW, Prados MD (1995) Pineoblastoma in adults. Neurosurgery 37(3):383–390 discussion 390–381

    Article  CAS  PubMed  Google Scholar 

  7. Herrlinger U, Steinbrecher A, Rieger J, Hau P, Kortmann RD, Meyermann R, Schabet M, Bamberg M, Dichgans J, Bogdahn U, Weller M (2005) Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol 252(3):291–299

    Article  PubMed  Google Scholar 

  8. Kim DG, Lee DY, Paek SH, Chi JG, Choe G, Jung HW (2002) Supratentorial primitive neuroectodermal tumors in adults. J Neurooncol 60(1):43–52

    Article  PubMed  Google Scholar 

  9. Lutterbach J, Fauchon F, Schild SE, Chang SM, Pagenstecher A, Volk B, Ostertag C, Momm F, Jouvet A (2002) Malignant pineal parenchymal tumors in adult patients: patterns of care and prognostic factors. Neurosurgery 51(1):44–55 discussion 55–46

    Article  PubMed  Google Scholar 

  10. Ohba S, Yoshida K, Hirose Y, Ikeda E, Kawase T (2008) A supratentorial primitive neuroectodermal tumor in an adult: a case report and review of the literature. J Neurooncol 86(2):217–224

    Article  PubMed  Google Scholar 

  11. Tate M, Sughrue ME, Rutkowski MJ, Kane AJ, Aranda D, McClinton L, McClinton L, Barani IJ, Parsa AT (2012) The long-term postsurgical prognosis of patients with pineoblastoma. Cancer 118(1):173–179

    Article  PubMed  Google Scholar 

  12. Gerber NU, von Hoff K, Friedrich C, von Bueren AO, Treulieb W, Benesch M, Faldum A, Pietsch T, Warmuth-Metz M, Rutkowski S, Kortmann R (2012) Hyperfractionated craniospinal radiochemotherapy followed by maintenance chemotherapy in children older than 4 years with supratentorial central nervous system primitive neuroectodermal tumor (stPNET) and pineoblastoma [abstract]. Neuro Oncol 14(Suppl 1):i95

    Google Scholar 

  13. Kleihues P, Cavenee WK (2000) World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. IARC, Lyon

    Google Scholar 

  14. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system. IARC, Lyon

    Google Scholar 

  15. Timmermann B, Kortmann RD, Kuhl J, Meisner C, Dieckmann K, Pietsch T, Bamberg M (2002) Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91. J Clin Oncol 20(3):842–849

    Article  PubMed  Google Scholar 

  16. von Hoff K, Hinkes B, Gerber NU, Deinlein F, Mittler U, Urban C, Benesch M, Warmuth-Metz M, Soerensen N, Zwiener I, Goette H, Schlegel PG, Pietsch T, Kortmann RD, Kuehl J, Rutkowski S (2009) Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT’91. Eur J Cancer 45(7):1209–1217

    Article  Google Scholar 

  17. Friedrich C, von Bueren AO, von Hoff K, Kwiecien R, Pietsch T, Warmuth-Metz M, Hau P, Deinlein F, Kuehl J, Kortmann RD, Rutkowski S (2013) Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study. Eur J Cancer 49(4):893–903

    Article  PubMed  Google Scholar 

  18. Friedrich C, von Bueren AO, von Hoff K, Gerber NU, Ottensmeier H, Deinlein F, Benesch M, Kwiecien R, Pietsch T, Warmuth-Metz M, Faldum A, Kuehl J, Kortmann RD, Rutkowski S (2013) Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol 15(2):224–234

    Article  CAS  PubMed  Google Scholar 

  19. Finkelstein DM (1986) A proportional hazards model for interval-censored failure time data. Biometrics 42(4):845–854

    Article  CAS  PubMed  Google Scholar 

  20. Cohen BH, Zeltzer PM, Boyett JM, Geyer JR, Allen JC, Finlay JL, McGuire-Cullen P, Milstein JM, Rorke LB, Stanley P et al (1995) Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial. J Clin Oncol 13(7):1687–1696

    CAS  PubMed  Google Scholar 

  21. Massimino M, Gandola L, Spreafico F, Luksch R, Collini P, Giangaspero F, Simonetti F, Casanova M, Cefalo G, Pignoli E, Ferrari A, Terenziani M, Podda M, Meazza C, Polastri D, Poggi G, Ravagnani F, Fossati-Bellani F (2006) Supratentorial primitive neuroectodermal tumors (S-PNET) in children: a prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy. Int J Radiat Oncol Biol Phys 64(4):1031–1037

    Article  PubMed  Google Scholar 

  22. Pizer B, Donachie PH, Robinson K, Taylor RE, Michalski A, Punt J, Ellison DW, Picton S (2011) Treatment of recurrent central nervous system primitive neuroectodermal tumours in children and adolescents: results of a Children’s Cancer and Leukaemia Group study. Eur J Cancer 47(9):1389–1397

    Article  PubMed  Google Scholar 

  23. Reddy AT, Janss AJ, Phillips PC, Weiss HL, Packer RJ (2000) Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy. Cancer 88(9):2189–2193

    Article  CAS  PubMed  Google Scholar 

  24. Greenberg HS, Chamberlain MC, Glantz MJ, Wang S (2001) Adult medulloblastoma: multiagent chemotherapy. Neuro Oncol 3(1):29–34

    CAS  PubMed Central  PubMed  Google Scholar 

  25. Jakacki RI, Zeltzer PM, Boyett JM, Albright AL, Allen JC, Geyer JR, Rorke LB, Stanley P, Stevens KR, Wisoff J et al (1995) Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group. J Clin Oncol 13(6):1377–1383

    CAS  PubMed  Google Scholar 

  26. Germanwala AV, Mai JC, Tomycz ND, Niranjan A, Flickinger JC, Kondziolka D, Lunsford LD (2008) Boost gamma knife surgery during multimodality management of adult medulloblastoma. J Neurosurg 108(2):204–209

    Article  PubMed  Google Scholar 

  27. Behdad A, Perry A (2009) Central nervous system primitive neuroectodermal tumors: a clinicopathologic and genetic study of 33 cases. Brain Pathol 20(2):441–450

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the participating centers for their valuable cooperation. Special thanks to Wiebke Treulieb and Christine Lindow (HIT data center) for their excellent data management, and to Katharina Petrasch for CSF reference assessments. The HIT 2000 trial office and the reference institutions are supported by the German Children’s Cancer Foundation (Deutsche Kinderkrebsstiftung).

Conflict of interest

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefan Rutkowski.

Additional information

André O.von Bueren and Stefan Rukowski are contributed equally.

Joachim Kuehl—Deceased.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Friedrich, C., Müller, K., von Hoff, K. et al. Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol. J Neurooncol 116, 567–575 (2014). https://doi.org/10.1007/s11060-013-1327-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-013-1327-8

Keywords

Navigation